Findings

What do systematic reviews say?

7 questions · 7 findings · 1 reviews · Musculoskeletal

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 2 · 28.6%Very low 2 · 28.6%Low 1 · 14.3%Moderate 2 · 28.6%High 0 · 0%

Autologous blood or PRP vs placebo at 3 months' follow‐up

Adverse events (pain and swelling at injection site and limitation of elbow movement following injection) · lateral elbow pain

Autologous blood or PRP showed no clear difference in adverse events (pain and swelling at injection site and limitation… compared with placebo at 3 months' follow‐up (low certainty).

1 finding from 1 review

Autologous blood and platelet‐rich plasma injection therapy for lateral elbow pain 2021 · Cochrane Headline outcomes only
RR 1.14 [0.76, 1.72]
5 studies · 425 participants
Low

Autologous blood or PRP vs placebo at 3 months' follow‐up

Pain (VAS, PRTEE) translated to 0 to 10, where 0 is no pain · lateral elbow pain

1 finding from 1 review

Autologous blood and platelet‐rich plasma injection therapy for lateral elbow pain 2021 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 523 participants
Moderate

Autologous blood or PRP vs placebo at 3 months' follow‐up

Disability DASH scale. Scale from: 0 to 100. ( · lateral elbow pain

1 finding from 1 review

Autologous blood and platelet‐rich plasma injection therapy for lateral elbow pain 2021 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 502 participants
Moderate

Autologous blood or PRP vs placebo at 3 months' follow‐up

Treatment success (> 25% improvement in pain or function) · lateral elbow pain

It is very uncertain whether autologous blood or PRP changes treatment success (> 25% improvement in pain or function) compared with placebo at 3 months' follow‐up (very low certainty).

1 finding from 1 review

Autologous blood and platelet‐rich plasma injection therapy for lateral elbow pain 2021 · Cochrane Headline outcomes only
RR 1 [0.83, 1.19]
4 studies · 372 participants
Very low

Autologous blood or PRP vs placebo at 3 months' follow‐up

Health‐related Quality of Life Not measured · lateral elbow pain

1 finding from 1 review

Autologous blood and platelet‐rich plasma injection therapy for lateral elbow pain 2021 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Autologous blood or PRP vs placebo at 3 months' follow‐up

Relief of pain · lateral elbow pain

1 finding from 1 review

Autologous blood and platelet‐rich plasma injection therapy for lateral elbow pain 2021 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Autologous blood or PRP vs placebo at 3 months' follow‐up

Withdrawals due to adverse events · lateral elbow pain

It is very uncertain whether autologous blood or PRP changes withdrawal due to adverse events Â compared with placebo at 3 months' follow‐up (very low certainty).

1 finding from 1 review

Autologous blood and platelet‐rich plasma injection therapy for lateral elbow pain 2021 · Cochrane Headline outcomes only
RR 0.32 [0.03, 2.92]
1 study · 80 participants
Very low